Skip to content. Skip to navigation
epa fitboard fuse lexicon oltramare ossesso swissair swisscom swissre
Events
Home > Activities > Events > Personalized Medicine: Changing the Face of Healthcare?
Sections
swissnex:
Swiss Knowledge Network with outposts in:
swissnex San Francisco connects the best of many worlds by bridging the knowledge, energy and competencies in science, higher education, art and innovation between Switzerland, the U.S.A and Canada. Initiated by the Swiss State Secretariat for Education and Research (SER) as a public-private venture, and managed in cooperation with the Swiss Department of Foreign Affairs, swissnex San Francisco is an annex of the Consulate General of Switzerland in San Francisco. Vital financial support is provided by public and private sponsors sharing swissnex' commitment to connecting the dots.
 

Personalized Medicine: Changing the Face of Healthcare?

During this breakfast discussion panel, three Bay Area senior executives will share their insights on the meaning and the future of the personalized medicine revolution.
29 Sep 2005 from 6:30 AM to 8:30 AM Pacific Time

Practical Information:

Location:
730 Montgomery Street, San Francisco CA 94111
Cost:
Free event
New understandings of disease diagnostics and treatment have fueled predictions of a transition from "sick-care" to more integrative health care systems. Recent withdrawals of blockbuster drugs Vioxx and Tysabri due to safety concerns highlight the dangers of a "one size fits all" drug development model. Taking the opposite approach, personalized medicine seeks to create differentiated strategies for the prevention and care of disease through the use of 'tailored' medications. Drawing from the convergence of pharmacogenomics and proteomics, personalized medicine promises to make the drug development process faster, cheaper and more effective while also improving drug safety. However, this paradigm shift also poses important ethical challenges (such as the need to balance commercial and public health priorities) that will need to be carefully addressed. During our breakfast discussion panel, three Bay Area senior executives will share their insights on the meaning and the future of the personalized medicine revolution, to which they have directly contributed as important actors within each of their respective companies.


Program:

7:30 to 8:00 light breakfast & networking
8:00 to 8:45 10 min talks by each of the 3 panelists
            • Dr. Bob Cohen, Senior Director, Business Development, Genentech
            • Thane Kreiner, Vice President, Corporate Affairs for Affymetrix,Inc.
            • Martin L. Verhoef, President of Ciphergen's Biosystems Division and an Executive Vice President of Ciphergen Biosystems, Inc.
            • Panel moderated by Dr. Heather Koshinsky, CEO, President and Co-founder, Investigen, Inc.
8:45 to 9:00 Q&A session with the audience
In partnership with


FACCSF - French-American Chamber of Commerce, San Francisco Chapter

BayBio - Northern California's Life Science Association

IMBS - Institute of Biomedical Science

qb3 - California Institute for Quantitative Biomedical Research
 

© 2007 Swissnex. All rights reserved. Sitemap | Contact Us | Privacy Policy